Actively Recruiting
Hamburg AoRtic Valve cOhoRt
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2020-01-13
15000
Participants Needed
1
Research Sites
1565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and anticipated clinical outcomes. This includes the association of demographic factors, procedural data and biomarkers with clinical outcome in a prospective fashion.
CONDITIONS
Official Title
Hamburg AoRtic Valve cOhoRt
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with clinically relevant aortic valve disease (aortic valve stenosis, aortic regurgitation, degenerated aortic valve prosthesis)
- Written informed consent
You will not qualify if you...
- Insufficient knowledge of the German language (able to understand and write the German language)
- Physical or psychological incapability to take part in the investigation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitäres Herz- und Gefäßzentrum
Hamburg, Germany, 20246
Actively Recruiting
Research Team
M
Moriz Seiffert, MD
CONTACT
N
Niklas Schofer, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here